Literature DB >> 31439115

Mass screening for active case finding of pulmonary tuberculosis in the Russian Federation: how to save costs.

E Bogdanova1, O Mariandyshev2, S G Hinderaker3, E Nikishova2, A Kulizhskaya4, O Sveshnikova4, A Grjibovski2, E Heldal3, A Mariandyshev2.   

Abstract

BACKGROUND: In Russia, mass chest X-ray (CXR) screening for tuberculosis (TB) is mandatory.
OBJECTIVE: To compare the yield and the cost per TB case detected and the total cost of CXR screening, passive case finding and contact tracing among adolescents and adults in the Arkhangelsk Oblast, Russian Federation, 2013-2017.
DESIGN: This was an analysis of costing strategies using aggregated data. Costing information was obtained from the Finance Department of the Arkhangelsk Clinical TB Dispensary, Arkhangelsk, and the Territorial Fund of Mandatory Medical Insurance, Arkhangelsk, Russian Federation.
RESULTS: TB cases were detected using CXR screening (n = 684, 46%), contact tracing (n = 61, 4%) and passive case finding (n = 743, 46%). The number of cases detected using CXR screening, contact tracing and passive case finding was respectively 28,753 and 960/100 000. The mean costs/test were respectively US$3.54 (US$12 541/case), US$20.28 (US$2693/case) and US$11.85 (US$1235/case) using CXR screening, contact tracing and passive case finding The number of cases/100 000 in targeted groups was as follows: HIV-positive persons, 645; homeless persons, 461; and migrants, 441. The cost/TB case detected was respectively US$549, US$768 and US$803.
CONCLUSION: Mass CXR screening (excluding HIV-positive, migrant and homeless populations) has low yield and high cost per TB case detected. It should be stopped and resources should instead be used to strengthen the screening of targeted high-risk groups, contacts and passive case finding.

Entities:  

Mesh:

Year:  2019        PMID: 31439115     DOI: 10.5588/ijtld.18.0449

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  3 in total

1.  Tuberculosis screening costs and cost-effectiveness in high-risk groups: a systematic review.

Authors:  H Alsdurf; B Empringham; C Miller; A Zwerling
Journal:  BMC Infect Dis       Date:  2021-09-08       Impact factor: 3.090

2.  Comparison of yield and relative costs of different screening algorithms for tuberculosis in active case-finding: a cross-section study.

Authors:  Fei Zhao; Canyou Zhang; Chongguang Yang; Yinyin Xia; Jin Xing; Guolong Zhang; Lin Xu; Xiaomeng Wang; Wei Lu; Jianwei Li; Feiying Liu; Dingwen Lin; Jianlin Wu; Xin Shen; Shuangyi Hou; Yanling Yu; Dongmei Hu; Chunyi Fu; Lixia Wang; Jun Cheng; Hui Zhang
Journal:  BMC Infect Dis       Date:  2021-08-13       Impact factor: 3.090

3.  Tuberculosis in the Western Pacific Region: Estimating the burden of disease and return on investment 2020-2030 in four countries.

Authors:  Janne Estill; Tauhid Islam; Rein M G J Houben; Jamie Rudman; Romain Ragonnet; Emma S McBryde; James M Trauer; Erol Orel; Anh Tuan Nguyen; Kalpeshsinh Rahevar; Fukushi Morishita; Kyung Hyun Oh; Mario C Raviglione; Olivia Keiser
Journal:  Lancet Reg Health West Pac       Date:  2021-04-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.